GLP-1

The Effects of LEUVATE on Glycemia, Insulinemia, Aminoacidemia, and Protein Synthesis in GLP-1 RA-treated Adults

The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion

GLP-1 Medicines and Mental Health Changes

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity

Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures

Comparative Cardiovascular Effectiveness of GLP-1 RAs vs. Insulin in Early-Onset Type 2 Diabetes

Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes

Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery

Effect of GIP After a Meal in Patients With Type 2 Diabetes

GLP-1 Inhibits Prandial Antro-duodeno-jejunal Motility in Humans

To Determine the Effect of GLP1 on Cognitive Function, Brain Glucose Metabolism and Neuroplasticity.

GLP-1 Loading During Elective Percutaneous Coronary Intervention

Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle

The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition

Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes

The Microvascular Function of GLP-1 and Its Analogues

Incretin Regulation of Insulin Secretion in Monogenic Diabetes